✦ LIBER ✦

Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease

✍ Scribed by Dénes Zádori; Andrea Geisz; Enikő Vámos; László Vécsei; Péter Klivényi

Book ID: 113841827
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 308 KB
Volume: 94
Category: Article
ISSN: 0091-3057
DOI: 10.1016/j.pbb.2009.08.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coenzyme Q10 and remacemide hydrochlorid

Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model

✍ Gabriele Schilling; Michael L Coonfield; Christopher A Ross; David R Borchelt 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 268 KB

A2A receptor knockout worsens survival a

A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease

✍ Stéphane Mievis; David Blum; Catherine Ledent 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 989 KB

Creatine Increases Survival and Delays M

Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease

✍ Ole A. Andreassen; Alpaslan Dedeoglu; Robert J. Ferrante; Bruce G. Jenkins; Kimb 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 482 KB

Gabapentin-lactam, but not gabapentin, r

Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington’s disease

✍ Birgit Zucker; Dagmar E. Ludin; Thomas A. Gerds; Carl H. Lücking; G. Bernhard La 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 293 KB

Riluzole prolongs survival time and alte

Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease

✍ Johannes Schiefer; G. Bernhard Landwehrmeyer; Hans-Gerd Lüesse; Arne Sprünken; C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Glutamate excitotoxicity has been suggested to contribute to the pathogenesis of Huntington's disease (HD). Riluzole is a substance with glutamate antagonistic properties that is used for neuroprotective treatment in amyotrophic lateral sclerosis and which is currently tested in clinical trials for

CGS21680 attenuates symptoms of Huntingt

CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model

✍ Szu-Yi Chou; Yi-Chao Lee; Hui-Mei Chen; Ming-Chang Chiang; Hsing-Lin Lai; Hao-Hu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB